RET+ NSCLC shares several radiologic features with ALK+ and ROS1+ NSCLC, including solid density of the primary tumor and high frequencies of lymphangitic carcinomatosis and pleural, brain, and bone metastases. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.